Insider Buy/Sell Details for the Biotechnology Industry — Last 7 Days
Ratio0.1:1
Daily Buy & Sell Volume
Transactions (331)
Werewolf Therapeutics, Inc. (HOWL)
EVNIN LUKE — Director
Shares
157,084
Price
$0.30
Total Value
$47.13K
Shares Held After
143,199
% of Holdings
52.3%
Pharvaris N.V. (PHVS)
Schikan Johannes Gerardus Christiaan Petrus — Director
Shares
2,400
Price
$35.10
Total Value
$84.25K
Shares Held After
352,767
% of Holdings
0.7%
CYTOKINETICS INC (CYTK)
Lee Sung — EVP, Chief Financial Officer
Shares
3,134
Price
$85.00
Total Value
$266.39K
Shares Held After
63,221
% of Holdings
4.7%
Imunon, Inc. (IMNN)
Eylward Susan — General Counsel and Corp Sec
Shares
11,800
Price
$1.75
Total Value
$20.67K
Shares Held After
2,896
% of Holdings
80.3%
Roivant Sciences Ltd. (ROIV)
MANCHESTER KEITH S — Director
Shares
325,000
Price
$34.07
Total Value
$11.07M
Shares Held After
14,501,546
% of Holdings
2.2%
Roivant Sciences Ltd. (ROIV)
MANCHESTER KEITH S — Director
Shares
300,783
Price
$33.92
Total Value
$10.20M
Shares Held After
14,826,546
% of Holdings
2.0%
Roivant Sciences Ltd. (ROIV)
Gold Daniel Allen — Director
Shares
325,000
Price
$34.07
Total Value
$11.07M
Shares Held After
14,501,546
% of Holdings
2.2%
Roivant Sciences Ltd. (ROIV)
Gold Daniel Allen — Director
Shares
300,783
Price
$33.92
Total Value
$10.20M
Shares Held After
14,826,546
% of Holdings
2.0%
Roivant Sciences Ltd. (ROIV)
QVT Financial LP — Director by Deputization
Shares
325,000
Price
$34.07
Total Value
$11.07M
Shares Held After
14,501,546
% of Holdings
2.2%
Roivant Sciences Ltd. (ROIV)
QVT Financial LP — Director by Deputization
Shares
300,783
Price
$33.92
Total Value
$10.20M
Shares Held After
14,826,546
% of Holdings
2.0%
Adaptive Biotechnologies Corp (ADPT)
BENZENO SHARON — Chief Commercial Ofc Imm Med
Shares
11,034
Price
$21.00
Total Value
$231.71K
Shares Held After
272,751
% of Holdings
3.9%
Dyne Therapeutics, Inc. (DYN)
Rhodes Jason P — Director
Shares
64,411
Price
$21.28
Total Value
$1.37M
Shares Held After
1,016,633
% of Holdings
6.0%
Dyne Therapeutics, Inc. (DYN)
Rhodes Jason P — Director
Shares
81,903
Price
$21.28
Total Value
$1.74M
Shares Held After
1,396,475
% of Holdings
5.5%
Dyne Therapeutics, Inc. (DYN)
Rhodes Jason P — Director
Shares
162,954
Price
$21.28
Total Value
$3.47M
Shares Held After
4,579,456
% of Holdings
3.4%
GALECTIN THERAPEUTICS INC (GALT)
Jamil Khurram — Chief Medical Officer
Shares
2,533
Price
$5.00
Total Value
$12.66K
Shares Held After
0
% of Holdings
100.0%
GALECTIN THERAPEUTICS INC (GALT)
Shlevin Harold H. — Director
Shares
7,732
Price
$5.00
Total Value
$38.66K
Shares Held After
6,500
% of Holdings
54.3%
GALECTIN THERAPEUTICS INC (GALT)
Jamil Khurram — Chief Medical Officer
Shares
2,037
Price
$5.00
Total Value
$10.19K
Shares Held After
0
% of Holdings
100.0%
Mineralys Therapeutics, Inc. (MLYS)
Warren Eric — Chief Commercial Officer
Shares
104,124
Price
$25.90
Total Value
$2.70M
Shares Held After
38,400
% of Holdings
73.1%
IONIS PHARMACEUTICALS INC (IONS)
O'NEIL PATRICK R. — EVP CLO & General Counsel
Shares
3,069
Price
$80.00
Total Value
$245.52K
Shares Held After
61,470
% of Holdings
4.8%
Disc Medicine, Inc. (IRON)
Yu Jonathan Yen-Wen — Chief Operating Officer
Shares
300
Price
$72.50
Total Value
$21.75K
Shares Held After
54,324
% of Holdings
0.5%
IONIS PHARMACEUTICALS INC (IONS)
Baroldi Joseph — EVP, Chief Business Officer
Shares
5,635
Price
$80.16
Total Value
$451.70K
Shares Held After
4,669
% of Holdings
54.7%
IONIS PHARMACEUTICALS INC (IONS)
Schneider Eugene — EVP, Chf Clinical Develop Ofcr
Shares
26,000
Price
$81.05
Total Value
$2.11M
Shares Held After
77,114
% of Holdings
25.2%
Disc Medicine, Inc. (IRON)
Khara Rahul — Chief Legal Officer
Shares
851
Price
$75.00
Total Value
$63.83K
Shares Held After
52,173
% of Holdings
1.6%
PTC THERAPEUTICS, INC. (PTCT)
Almstead Neil Gregory — CHIEF TECHNICAL OPS OFFICER
Shares
7,718
Price
$85.26
Total Value
$658.04K
Shares Held After
60,137
% of Holdings
11.4%
PTC THERAPEUTICS, INC. (PTCT)
Almstead Neil Gregory — CHIEF TECHNICAL OPS OFFICER
Shares
412
Price
$85.23
Total Value
$35.11K
Shares Held After
60,137
% of Holdings
0.7%
uniQure N.V. (QURE)
Abi-Saab Walid — Chief Medical Officer
Shares
1,434
Price
$46.86
Total Value
$67.20K
Shares Held After
168,235
% of Holdings
0.8%
Kymera Therapeutics, Inc. (KYMR)
Booth Bruce — Director
Shares
1,729
Price
$118.66
Total Value
$205.16K
Shares Held After
472,267
% of Holdings
0.4%
Kymera Therapeutics, Inc. (KYMR)
Booth Bruce — Director
Shares
3,069
Price
$117.85
Total Value
$361.68K
Shares Held After
473,996
% of Holdings
0.6%
Kymera Therapeutics, Inc. (KYMR)
Booth Bruce — Director
Shares
1,701
Price
$117.09
Total Value
$199.17K
Shares Held After
477,065
% of Holdings
0.4%
Kymera Therapeutics, Inc. (KYMR)
Booth Bruce — Director
Shares
952
Price
$115.69
Total Value
$110.14K
Shares Held After
478,766
% of Holdings
0.2%
Kymera Therapeutics, Inc. (KYMR)
Booth Bruce — Director
Shares
3,896
Price
$114.94
Total Value
$447.81K
Shares Held After
479,718
% of Holdings
0.8%
Kymera Therapeutics, Inc. (KYMR)
Booth Bruce — Director
Shares
2,083
Price
$113.97
Total Value
$237.40K
Shares Held After
483,614
% of Holdings
0.4%
Kymera Therapeutics, Inc. (KYMR)
Booth Bruce — Director
Shares
78
Price
$112.49
Total Value
$8.77K
Shares Held After
485,697
% of Holdings
0.0%
Kymera Therapeutics, Inc. (KYMR)
Booth Bruce — Director
Shares
1,442
Price
$111.51
Total Value
$160.80K
Shares Held After
485,775
% of Holdings
0.3%
Kymera Therapeutics, Inc. (KYMR)
Booth Bruce — Director
Shares
1,579
Price
$110.49
Total Value
$174.46K
Shares Held After
487,217
% of Holdings
0.3%
Kymera Therapeutics, Inc. (KYMR)
Booth Bruce — Director
Shares
4,562
Price
$109.79
Total Value
$500.86K
Shares Held After
488,796
% of Holdings
0.9%
Kymera Therapeutics, Inc. (KYMR)
Booth Bruce — Director
Shares
32,402
Price
$108.14
Total Value
$3.50M
Shares Held After
493,358
% of Holdings
6.2%
Kymera Therapeutics, Inc. (KYMR)
Booth Bruce — Director
Shares
3,958
Price
$107.57
Total Value
$425.76K
Shares Held After
525,760
% of Holdings
0.7%
Kymera Therapeutics, Inc. (KYMR)
Booth Bruce — Director
Shares
12,390
Price
$118.66
Total Value
$1.47M
Shares Held After
2,451,924
% of Holdings
0.5%
Kymera Therapeutics, Inc. (KYMR)
Booth Bruce — Director
Shares
22,046
Price
$117.85
Total Value
$2.60M
Shares Held After
2,464,314
% of Holdings
0.9%
Kymera Therapeutics, Inc. (KYMR)
Booth Bruce — Director
Shares
12,181
Price
$117.09
Total Value
$1.43M
Shares Held After
2,486,360
% of Holdings
0.5%
Kymera Therapeutics, Inc. (KYMR)
Booth Bruce — Director
Shares
6,821
Price
$115.69
Total Value
$789.12K
Shares Held After
2,498,541
% of Holdings
0.3%
Kymera Therapeutics, Inc. (KYMR)
Booth Bruce — Director
Shares
27,951
Price
$114.94
Total Value
$3.21M
Shares Held After
2,505,362
% of Holdings
1.1%
Kymera Therapeutics, Inc. (KYMR)
Booth Bruce — Director
Shares
14,913
Price
$113.97
Total Value
$1.70M
Shares Held After
2,533,313
% of Holdings
0.6%
Kymera Therapeutics, Inc. (KYMR)
Booth Bruce — Director
Shares
555
Price
$112.49
Total Value
$62.43K
Shares Held After
2,548,226
% of Holdings
0.0%
Kymera Therapeutics, Inc. (KYMR)
Booth Bruce — Director
Shares
10,366
Price
$111.51
Total Value
$1.16M
Shares Held After
2,548,781
% of Holdings
0.4%
Kymera Therapeutics, Inc. (KYMR)
Booth Bruce — Director
Shares
11,277
Price
$110.49
Total Value
$1.25M
Shares Held After
2,559,147
% of Holdings
0.4%
Kymera Therapeutics, Inc. (KYMR)
Booth Bruce — Director
Shares
32,624
Price
$109.79
Total Value
$3.58M
Shares Held After
2,570,424
% of Holdings
1.3%
Kymera Therapeutics, Inc. (KYMR)
Booth Bruce — Director
Shares
231,007
Price
$108.14
Total Value
$24.98M
Shares Held After
2,603,048
% of Holdings
8.2%
Kymera Therapeutics, Inc. (KYMR)
Booth Bruce — Director
Shares
28,296
Price
$107.57
Total Value
$3.04M
Shares Held After
2,834,055
% of Holdings
1.0%
Showing 51–100 of 331 transactions (page 2 of 7)